SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NKTR Drug delivery Company
An SI Board Since September 2005
Posts SubjectMarks Bans Symbol
507 31 0 NKTR
Emcee:  david nordic Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
357Major FDA decisions coming up in March---- 3/26 is date for FDA action on the (Arthur Radley-1/9/2012
356Yes I believe all the additional patients will have had Doxil. I didn't recghmm-3/16/2011
355They did say that phase III will start in 1H '12 so not waiting for full phaidos-3/16/2011
354They don't need to wait until full P2 data to begin. Interesting on the 12rkrw-3/16/2011
353The official line is that even if they get accelerated approval would need the Pghmm-3/16/2011
352NKTR did say (after meeting with the FDA in Feb), it is planing to start a randoidos-3/16/2011
351I agree but am hoping to be wrong :-). I don't do a lot of investing in oncghmm-3/15/2011
350Approval with just a single arm p2 would seem to be quite a long shot. Slim to nrkrw-3/15/2011
349Anyone have thoughts on the Phase 2 <b>Ovarian</b> data seen thus-faghmm-3/15/2011
348Secondary completed and NKTR pockets more than $200M---so maybe that will fund oArthur Radley-1/24/2011
347The CEO really threw us a curve ball, after being so forceful about doing a partArthur Radley-12/14/2010
346Phase 2 Data Presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Syidos-12/14/2010
345ir.nektar.com NKTR will have a presentation tomorrow(Sunday 12-12) beginning atArthur Radley-12/11/2010
344UPDATE 1-Nektar to supply polymer to Amgen, to get $50 mln 8:01 am ET 11/02/2010Arthur Radley-11/2/2010
343nektar.comArthur Radley-11/1/2010
342ucb.presscentre.com Cimzia appears to be ramping up in revenue ---good for NKTRArthur Radley-10/23/2010
341Stock continues to move up nicely -- however, without some partnership announcemArthur Radley-10/18/2010
340blogs.forbes.com Interesting article in today's Forbes blog.Arthur Radley-9/10/2010
339online.barrons.com 4 months and holding........deal is important to get this stArthur Radley-8/25/2010
338Stock has been strong and with Q report coming out after the close........added Arthur Radley-7/28/2010
337Dew, Thanks for the info......stock has really be active over the last few days.Arthur Radley-7/26/2010
336Cary, Roche can’t launch Mircera in the US until mid 2014: see siliconinvestor.cDewDiligence_on_SI-7/25/2010
335Roche reported Q results this week....they indicated Mircera revenue was up to 1Arthur Radley-7/24/2010
334There was a research PR within the past week that claimed Inhaled Insulin restorIan@SI-7/20/2010
333MannKind still fighting, resubmitted its NDA, with an action date in December. tuck-7/20/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News